Salvage therapy for hepatocellular carcinoma with thalidomide

AIM: To evaluate the clinical benefit of thalidomide in patients with advanced hepatocellular carcinoma (hepatoma). METHODS: From March 2000 to July 2002, patients who had advanced hepatocellular carcinoma and failed to or were unsuited for aggressive treatment, were enrolled and took thalidomide 15...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:World J Gastroenterol
Autori principali: Wang, Tsang-En, Kao, Chin-Roa, Lin, Shee-Chan, Chang, Wen-Hsiung, Chu, Cheng-Hsin, Lin, Johson, Hsieh, Ruey-Kuen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Inc 2004
Soggetti:
Liver Cancer
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716902/
https://ncbi.nlm.nih.gov/pubmed/14991931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i5.649
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi